These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6034264)

  • 1. Incorporation of pyrimidines and boron analogues into brain tumour and brain tissue of mice. An approach to boron-neutron capture therapy.
    Hatanaka H; Soloway AH; Sweet H
    Neurochirurgia (Stuttg); 1967 May; 10(3):87-95. PubMed ID: 6034264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Utilization of pyrimidine precursors in the tumor and liver of mice with Ehrlich ascites carcinoma].
    Fedorov NA; Matveenko VN; Tikhonova EF
    Biull Eksp Biol Med; 1970 Dec; 70(12):66-9. PubMed ID: 5503816
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
    Shapiro WR
    Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762
    [No Abstract]   [Full Text] [Related]  

  • 4. [10B compound distribution in rat tissue of transplanted and ethylnitrosourea-induced brain tumors].
    Abe M
    Fukuoka Igaku Zasshi; 1982 May; 73(5):250-71. PubMed ID: 7129329
    [No Abstract]   [Full Text] [Related]  

  • 5. Boron neutron capture therapy of cancer.
    Barth RF; Soloway AH; Fairchild RG
    Cancer Res; 1990 Feb; 50(4):1061-70. PubMed ID: 2404588
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the long-term selective uptake of boron by tumors other than brain tumors: its possible use in neutron-capture cancer therapy.
    Anghileri LJ; Miller ES
    Strahlentherapie; 1971 Apr; 141(4):404-8. PubMed ID: 5557114
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose analogues as potential agents for brain tumour diagnosis and treatment.
    Wassenaar W; Tator CH
    Trans Am Neurol Assoc; 1973; 98():43-8. PubMed ID: 4784973
    [No Abstract]   [Full Text] [Related]  

  • 8. The uptake of tritiated methotrexate by an experimental glioma.
    Tator CH
    Cancer Res; 1971 Nov; 31(11):1600-5. PubMed ID: 5121663
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of catabolism in pyrimidine utilization for nucleic acid synthesis in vivo.
    Cooper GM; Dunning WF; Greer S
    Cancer Res; 1972 Feb; 32(2):390-7. PubMed ID: 5058194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of a pyrimidine-dependent mutant for effective labeling of the DNA OF Aspergillus nidulans].
    Zinchenko VB; Groshev BV; Kameneva SV
    Mikrobiologiia; 1978; 47(6):1044-8. PubMed ID: 370508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neutron capture therapy of malignant neoplasms].
    Riabukhin IuS
    Med Radiol (Mosk); 1970 Aug; 15(8):81-91. PubMed ID: 4921837
    [No Abstract]   [Full Text] [Related]  

  • 12. [Present status of the problem of the structure and chemism of experimental brain neoplasms].
    Avtsyn AP; Abdullakhodzhaeva MS
    Usp Sovrem Biol; 1970; 70(3):430-42. PubMed ID: 4324487
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors.
    Zhuo JC; Cai J; Soloway AH; Barth RF; Adams DM; Ji W; Tjarks W
    J Med Chem; 1999 Apr; 42(7):1282-92. PubMed ID: 10197971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of boron nanocapsules for neutron capture therapy.
    Nakamura H; Ueno M; Ban HS; Nakai K; Tsuruta K; Kaneda Y; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma.
    Levin VA; Clancy TP; Ausman JI; Rall DP
    J Natl Cancer Inst; 1972 Apr; 48(4):875-83. PubMed ID: 4537157
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
    Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
    Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
    Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
    Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of sodium borocaptate and buthionine sulfoximine in boron neutron capture therapy enhanced tissue boron uptake and delayed tumor growth in a rat subcutaneous tumor model.
    Yoshida F; Yamamoto T; Nakai K; Kumada H; Shibata Y; Tsuruta W; Endo K; Tsurubuchi T; Matsumura A
    Cancer Lett; 2008 May; 263(2):253-8. PubMed ID: 18272285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of corticosteroid hormones in an experimental brain tumour model.
    Shapiro WR
    Afr J Med Sci; 1973 Oct; 4(4):351-8. PubMed ID: 4792050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.